Evolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Fiona Thistlethwaite
Advertisement
Articles by Fiona Thistlethwaite
Advertisement
Latest Updated Articles
- Facilitating Adoptive Cell Therapy Clinical Trials
Published: December 9th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
